TTLL11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.281400E-01
Normal-vs-Stage2
2.017200E-01
Normal-vs-Stage3
2.199700E-03
Normal-vs-Stage4
8.931600E-01
Stage1-vs-Stage2
2.332600E-01
Stage1-vs-Stage3
6.790100E-02
Stage1-vs-Stage4
7.443200E-01
Stage2-vs-Stage3
3.137800E-03
Stage2-vs-Stage4
2.074200E-01
Stage3-vs-Stage4
1.031760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.070400E-01
Normal-vs-AfricanAmerican
4.800800E-01
Normal-vs-Asian
3.083200E-01
Caucasian-vs-AfricanAmerican
5.674600E-01
Caucasian-vs-Asian
5.553200E-01
AfricanAmerican-vs-Asian
4.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.196200E-01
Normal-vs-Female
4.186000E-01
Male-vs-Female
3.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.638800E-01
Normal-vs-Age(41-60Yrs)
4.437400E-01
Normal-vs-Age(61-80Yrs)
2.482000E-01
Normal-vs-Age(81-100Yrs)
1.864170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.928800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.759000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.283600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.205200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.094800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.501570E-02
Normal-vs-Daily Drinker
4.916500E-02
Normal-vs-Weekly Drinker
3.546800E-01
Normal-vs-Occasional Drinker
1.088980E-01
Normal-vs-Social Drinker
9.679000E-01
Non Drinker-vs-Daily Drinker
4.685400E-01
Non Drinker-vs-Weekly Drinker
2.825600E-01
Non Drinker-vs-Occasional Drinker
7.202800E-01
Non Drinker-vs-Social Drinker
5.608500E-02
Daily Drinker-vs-Weekly Drinker
5.176800E-01
Daily Drinker-vs-Occasional Drinker
8.265000E-01
Daily Drinker-vs-Social Drinker
9.552400E-02
Weekly Drinker-vs-Occasional Drinker
4.480400E-01
Weekly Drinker-vs-Social Drinker
2.503000E-01
Occasional Drinker-vs-Social Drinker
8.795700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.561000E-01
Normal-vs-Grade 2
4.745400E-01
Normal-vs-Grade 3
4.656200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.043610E-01
Grade 1-vs-Grade 3
8.675900E-02
Grade 1-vs-Grade 4
3.561000E-01
Grade 2-vs-Grade 3
8.032400E-01
Grade 2-vs-Grade 4
4.745400E-01
Grade 3-vs-Grade 4
4.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.141600E-01
Normal-vs-NonDiabetic
2.551800E-01
Diabetic-vs-NonDiabetic
9.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.270800E-01
Normal-vs-NoPancreatitis
2.105600E-01
Pancreatitis-vs-NoPancreatitis
9.827000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.833000E-01
Normal-vs-N1
1.910620E-01
N0-vs-N1
2.940000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.205800E-02
Normal-vs-TP53-NonMutant
9.286800E-01
TP53-Mutant-vs-TP53-NonMutant
4.32890000001684E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
